Firm: Tasly Pharmaceutical Group Firm Restricted
Bloomberg ticker: 600535 SH
Market cap: US$2,860m
Background: Tasly Pharmaceutical Group Firm Restricted manufactures drug merchandise. The Firm develops and sells conventional Chinese language medication, organic medication, chemical medication, and different associated merchandise.
- Worthwhile Progress rank of 8 was up in comparison with the prior interval’s ninth rank
- That is beneath common efficiency in comparison with 380 giant Well being Care corporations worldwide
- Profitability rank of seven was higher than its Progress rank of 9
- Profitability rank of seven was up in comparison with the prior interval’s ninth rank
- That is beneath common efficiency in comparison with friends
- Progress rank of 9 was up in comparison with the prior interval’s tenth rank
- That is poor efficiency in comparison with friends
DISCLAIMER: This content material is for info functions solely. It isn’t meant to be funding recommendation. Readers mustn’t think about statements made by the writer(s) as formal suggestions and will seek the advice of their monetary advisor earlier than making any funding selections. Whereas the data offered is believed to be correct, it could embody errors or inaccuracies. The writer(s) can’t be held accountable for any actions taken because of studying this text.
#World #Class #Benchmarking #Tasly #Pharmaceutical #Group #Firm